DAB2IP and Familial prostate cancer: Kong Z and colleagues present evidence suggesting that DAB2IP-deficient prostate cancer cells that have metastasized show greater clonogenic survival when treated with ionizing radiation than control cells expressing normal levels of DAB2IP.